These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25799902

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India.
    Das K, Banerjee M, Mondal GP, Devi LG, Singh OP, Mukherjee BB.
    Seizure; 2007 Oct; 16(7):601-7. PubMed ID: 17576079
    [Abstract] [Full Text] [Related]

  • 46. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy.
    Markowitz MA, Mauskopf JA, Halpern MT.
    Neurology; 1998 Oct; 51(4):1026-33. PubMed ID: 9781524
    [Abstract] [Full Text] [Related]

  • 47. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs.
    Selai CE, Smith K, Trimble MR.
    Seizure; 1999 Feb; 8(1):8-13. PubMed ID: 10091841
    [Abstract] [Full Text] [Related]

  • 48. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
    Rychlik R, Pfeil T, Daniel D, Pfeil B, Mast O, Thate-Waschke I, Lorenz J.
    Dtsch Med Wochenschr; 2001 Mar 30; 126(13):353-9. PubMed ID: 11332229
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
    Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2014 Mar 30; 32():135-41. PubMed ID: 24561658
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
    Borghs S, Byram L, Chan J, Dedeken P, Logan J, Kiri V, Noack-Rink M, Patsalos PN, Thieffry S.
    BMC Neurol; 2020 Jan 08; 20(1):7. PubMed ID: 31914953
    [Abstract] [Full Text] [Related]

  • 53. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B, Hauser I, Horstmann V, Jokeit G, Liem S, May T, Meinert T, Robertson E, Schorlemmer H, Wagner W, Seidel M.
    Seizure; 2007 Jan 08; 16(1):35-42. PubMed ID: 17157535
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France].
    Fagnani F, Vespignani H, Kusnik-Joinville O, Bertrand M, Murat C, Lévy-Bachelot L, Kahane P.
    Presse Med; 2013 Sep 08; 42(9 Pt 1):e285-92. PubMed ID: 23601908
    [Abstract] [Full Text] [Related]

  • 56. [Antiepileptic treatment nearly six times more expensive since 1990].
    Persson PM, Russom A, Tomson T.
    Lakartidningen; 2003 Jan 09; 100(1-2):42-6. PubMed ID: 12572136
    [Abstract] [Full Text] [Related]

  • 57. Annual direct medical cost and contributing factors to total cost of epilepsy in Oman.
    Al-Zakwani I, Hanssens Y, Deleu D, Cohen A, McGhan W, Al-Balushi K, Al-Hashar A.
    Seizure; 2003 Dec 09; 12(8):555-60. PubMed ID: 14630493
    [Abstract] [Full Text] [Related]

  • 58. Comprehensive care of the epilepsy patient--control, comorbidity, and cost.
    Bazil CW.
    Epilepsia; 2004 Dec 09; 45 Suppl 6():3-12. PubMed ID: 15315510
    [Abstract] [Full Text] [Related]

  • 59. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).
    Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F, EPICOS Group.
    Epilepsia; 2004 Feb 09; 45(2):171-8. PubMed ID: 14738425
    [Abstract] [Full Text] [Related]

  • 60. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D, WHO-CHOICE.
    Epilepsia; 2005 May 09; 46(5):751-9. PubMed ID: 15857443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.